Sep 29, 2025 18:30
SILO - Silo Pharma, Inc. Common Stock
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
0.6 0.01 (1.67%) | --- | --- | 0.0 (-0.33%) | 0.01 (1.67%) | --- | -0.02 (-3.98%) | -0.01 (-2.38%) |
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
PreMarket
Earnings & Ratios
- Basic EPS:
- -0.23
- Diluted EPS:
- -0.23
- Basic P/E:
- -2.6522
- Diluted P/E:
- -2.6522
- RSI(14) 1m:
- 0.0
- VWAP:
- 0.61
- RVol:
- 0.0026
Events
Period | Kind | Movement | Occurred At |
---|---|---|---|
1m | Price decrease 1m | 0.6 -0.01 (-1.28%) | Oct 15 05:40 |
60m | Price decrease 60m | 0.6 -0.03 (-5.12%) | Oct 14 19:59 |
Related News
Feb 11, 2025 12:45
Jan 02, 2025 13:45
Jul 19, 2024 16:28
Jul 19, 2024 16:02
Jul 19, 2024 12:02
Jul 17, 2024 10:03
Jun 26, 2024 12:50
Jun 07, 2024 12:18
Jun 06, 2024 20:50